These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

209 related articles for article (PubMed ID: 29901607)

  • 21. Severe refractory TAFRO syndrome requiring continuous renal replacement therapy complicated with
    Hibi A; Mizuguchi K; Yoneyama A; Kasugai T; Kamiya K; Kamiya K; Ito C; Kominato S; Miura T; Koyama K
    Ren Replace Ther; 2018; 4(1):16. PubMed ID: 34171004
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Castleman-Kojima disease (TAFRO syndrome) : a novel systemic inflammatory disease characterized by a constellation of symptoms, namely, thrombocytopenia, ascites (anasarca), microcytic anemia, myelofibrosis, renal dysfunction, and organomegaly : a status report and summary of Fukushima (6 June, 2012) and Nagoya meetings (22 September, 2012).
    Kawabata H; Takai K; Kojima M; Nakamura N; Aoki S; Nakamura S; Kinoshita T; Masaki Y
    J Clin Exp Hematop; 2013; 53(1):57-61. PubMed ID: 23801135
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Renal histology in a patient with TAFRO syndrome: a case report.
    Mizuno H; Sekine A; Oguro M; Oshima Y; Kawada M; Sumida K; Yamanouchi M; Hayami N; Suwabe T; Hiramatsu R; Hasegawa E; Hoshino J; Sawa N; Fujii T; Takaichi K; Ohashi K; Ubara Y
    Hum Pathol; 2018 Dec; 82():258-263. PubMed ID: 29626596
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Computed tomography findings of early-stage TAFRO syndrome and associated adrenal abnormalities.
    Kurokawa R; Gonoi W; Yokota H; Isshiki S; Ohira K; Mizuno H; Kiguchi T; Inui S; Kurokawa M; Kato S; Matsuki M; Takeda T; Yokoyama K; Ota Y; Nakai Y; Maeda E; Mori H; Abe O
    Eur Radiol; 2020 Oct; 30(10):5588-5598. PubMed ID: 32440781
    [TBL] [Abstract][Full Text] [Related]  

  • 25. An anterior mediastinal lesion in TAFRO syndrome showing complete remission after glucocorticoid and tocilizumab therapy.
    Sakashita K; Murata K; Inagaki Y; Oota S; Takamori M
    Respirol Case Rep; 2016 Sep; 4(5):e00173. PubMed ID: 27516889
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Acute Kidney Injury Caused by TAFRO Syndrome in a Chinese Patient: Efficacy of Long-Term Corticosteroids Combined with Bortezomib and Cyclophosphamide.
    Xia P; Zhang L; Zou M; Zhang T; Li R; Shi X; Wang J; Qin Y; Li X; Li J; Chen L
    Kidney Blood Press Res; 2020; 45(4):623-630. PubMed ID: 32492687
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Development of severe thrombocytopenia with TAFRO syndrome-like features in a patient with rheumatoid arthritis treated with a Janus kinase inhibitor: A case report.
    Kadoba K; Waki D; Nishimura K; Mukoyama H; Saito R; Murabe H; Yokota T
    Medicine (Baltimore); 2020 Oct; 99(42):e22793. PubMed ID: 33080751
    [TBL] [Abstract][Full Text] [Related]  

  • 28. A Case of Repeated TAFRO Syndrome-Like Symptoms and Retroperitoneal Hemorrhage in a Patient With Sjögren Syndrome.
    Ohta T; Oda N; Saito K; Tamiya S; Ueno T
    Cureus; 2020 Dec; 12(12):e12175. PubMed ID: 33489586
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Clinical features and treatment of 7 Chinese TAFRO syndromes from 96 de novo Castleman diseases: a 10-year retrospective study.
    Zhang Y; Suo SS; Yang HJ; Zhou XP; You LS; Yu WJ; Wang ZM; Jin J
    J Cancer Res Clin Oncol; 2020 Feb; 146(2):357-365. PubMed ID: 31938902
    [TBL] [Abstract][Full Text] [Related]  

  • 30. FDG PET/CT Findings in TAFRO Syndrome.
    Hotta M; Minamimoto R; Yashima A; Nakano M; Yamashita H
    Clin Nucl Med; 2018 Nov; 43(11):828-829. PubMed ID: 30222681
    [TBL] [Abstract][Full Text] [Related]  

  • 31. TAFRO Syndrome.
    Igawa T; Sato Y
    Hematol Oncol Clin North Am; 2018 Feb; 32(1):107-118. PubMed ID: 29157612
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Multicentric Castleman's disease associated with glomerular microangiopathy and MPGN-like lesion: does vascular endothelial cell-derived growth factor play causative or protective roles in renal injury?
    Seida A; Wada J; Morita Y; Baba M; Eguchi J; Nishimoto N; Okino T; Ichimura K; Yoshino T; Makino H
    Am J Kidney Dis; 2004 Jan; 43(1):E3-9. PubMed ID: 14712466
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Two patients with TAFRO syndrome exhibiting strikingly similar anterior mediastinal lesions with predominantly fat attenuation on chest computed tomography.
    Ozawa Y; Yamamoto H; Yasuo M; Takahashi H; Tateishi K; Ushiki A; Kawakami S; Fujinaga Y; Asaka S; Sano K; Takayama H; Imamura H; Hanaoka M
    Respir Investig; 2017 Mar; 55(2):176-180. PubMed ID: 28274535
    [TBL] [Abstract][Full Text] [Related]  

  • 34. TAFRO syndrome: New subtype of idiopathic multicentric Castleman disease.
    Srkalovic G; Marijanovic I; Srkalovic MB; Fajgenbaum DC
    Bosn J Basic Med Sci; 2017 May; 17(2):81-84. PubMed ID: 28135567
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Castleman disease mimicking systemic lupus erythematosus: A case report.
    Wang L; Chen H; Shi J; Tang H; Li H; Zheng W; Zhang F
    Medicine (Baltimore); 2018 Sep; 97(38):e12291. PubMed ID: 30235674
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Is TAFRO syndrome a subtype of idiopathic multicentric Castleman disease?
    Fujimoto S; Sakai T; Kawabata H; Kurose N; Yamada S; Takai K; Aoki S; Kuroda J; Ide M; Setoguchi K; Tsukamoto N; Iwao-Kawanami H; Kawanami T; Mizuta S; Fukushima T; Masaki Y
    Am J Hematol; 2019 Sep; 94(9):975-983. PubMed ID: 31222819
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Hepatic Campylobacter jejuni infection in patients with Castleman-Kojima disease (idiopathic multicentric Castleman disease with thrombocytopenia, anasarca, fever, reticulin fibrosis, and organomegaly (TAFRO) syndrome).
    Kageyama C; Igawa T; Gion Y; Iwaki N; Tabata T; Tanaka T; Kondo E; Sakai H; Tsuneyama K; Nomoto K; Noguchi H; Yoshino T; Yokota K; Sato Y
    Pathol Int; 2019 Oct; 69(10):572-579. PubMed ID: 31631463
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Fatal case of TAFRO syndrome with unilateral adrenal hemorrhage in early-stage disease.
    Okamoto T; Ochi S; Motokawa Y; Azumi H; Kobayashi S; Nakamura F; Nakatani T; Yagi H
    J Clin Exp Hematop; 2021; 61(2):109-113. PubMed ID: 34092711
    [TBL] [Abstract][Full Text] [Related]  

  • 39. TAFRO Syndrome in a Kidney Transplant Recipient That Was Diagnosed on Autopsy: A Case Report.
    Nagai M; Uchida T; Yamada M; Komatsu S; Ota K; Mukae M; Iwamoto H; Hirano H; Karube M; Kaname S; Oda T
    Front Med (Lausanne); 2021; 8():747678. PubMed ID: 34671626
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Successful treatment of TAFRO syndrome, a variant type of multicentric Castleman disease with thrombotic microangiopathy, with anti-IL-6 receptor antibody and steroids.
    Fujiwara S; Mochinaga H; Nakata H; Ohshima K; Matsumoto M; Uchiba M; Mikami Y; Hata H; Okuno Y; Mitsuya H; Nosaka K
    Int J Hematol; 2016 Jun; 103(6):718-23. PubMed ID: 26980221
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.